We fund and support research that could slow, stop or reverse Parkinson’s
2026: reflecting on the last year’s research progress and looking at what’s ahead
2025 was one of our most exciting years yet for Parkinson’s research. We saw the launch of EJS ACT-PD, the world’s largest clinical trial for Parkinson’s, the start of recruitment for the phase 3 trial of ambroxol, the forging of new strategic partnerships, and much more. Now, we’re looking back at some of the developments that defined 2025 and seeing what may be in store in 2026.
Latest news and events
Curing Parkinson’s through research
We’re here for the cure, and everything we do is to move us closer to that goal. We believe that collaboration between researchers, scientists, patients and funders is the key to accelerating promising treatments that will benefit people living with Parkinson’s.
Get involved to cure Parkinson’s
Our incredible supporters are the people who make our research projects possible. See how you can get involved to help us find a cure for everyone with Parkinson’s.
Upcoming fundraising events
See our latest fundraising events and find out how you can take part.
Work with us to cure Parkinson’s
We fund both preclinical and clinical research projects that have the potential to treat Parkinson’s from researchers and clinicals across the globe. Join us to help find a cure.
